$29.25
+1.40%Price chart
Sep 21Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20
Key dataOct 20, 2026
Open$29.14
From 52W high−21.32%
Volume705650.00
Market cap$12.24B
P/E (TTM)19.5x
P/S (TTM)1.9x
Div yield2.66%
Key dataOct 20, 2026
Open
$29.14
From 52W high
−21.32%
Volume
705650.00
Market cap
$12.24B
ValuationView details →
P/E (Fwd)
13.1x
EV/EBITDA
10.2x
P/E (TTM)
19.5x
RSI (14)
67.4
MomentumView details →
1D Return
+1.40%
YTD Return
−10.84%
SummaryUpdated Jun 1, 2026
Smith & Nephew plc (NYSE:SNN) is a British multinational medical technology company founded in 1856 and headquartered in Watford, United Kingdom. Originally established as a pharmacy business by Thomas James Smith, the company has evolved over more than 165 years into one of the world's leading medical device manufacturers. Smith & Nephew went public on the New York Stock Exchange in 1999 and today operates globally, serving healthcare providers across established and emerging markets. The company has undergone significant strategic transformation in recent years, implementing a comprehensive 12-point improvement plan to enhance operational efficiency and drive consistent growth across its medical device portfolio.
Similar companies
Latest newsMore news →
The UK and India’s CETA Marketplace is scheduled to take place in Mumbai on October 13, bringing together UK ministers, seven Northern England mayors and more than 100 British businesses to explore trade and investment opportunities.10d agoSmith+Nephew announced the commercial launch in Europe of CARTIHEAL AGILI-C, an implant for cartilage repair, to be presented at the ICRS Summit in Porto, Portugal, from October 8 to 10.15d ago